Ridgeback Capital — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

Ironwood Pharmaceuticalsironwoodpharma.com in 𝕏Sep 2016

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.

BiotechDigital HealthHealthtechCambridge, US

PETER M. HECHT(Executive Officer, Director)MARK G. CURRIE(Executive Officer)HALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)

BoardTERRANCE G. MCGUIRE(Director)

Co-investorsF-Prime Capital Mountain Group Capital Venrock Maverick Ventures Polaris Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.